Meeting Banner
Abstract #4344

Ferumoxytol as an Intravenous Contrast Agent for Relative Cerebral Blood Volume (RCBV) Measurements by MRI in Rats at 9.4 Tesla

Andreas Pohlmann1, Babette Wagenhaus1, Thoralf Niendorf1, 2

1Berlin Ultrahigh Field Facility, Max Delbrueck Center for Molecular Medicine, Berlin, Germany; 2Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charit Medical Faculty and the Max-Delbrck-Center, Berlin, Germany

Monitoring changes in blood volume with the use of intravascular contrast agents is of great interest for rodent studies of cerebrovascular diseases, fMRI and cerebrovascular reactivity. Ferumoxytol is a new intravenous iron preparation for treatment of the anemia of chronic kidney disease. It is a carbohydrate-coated USPIO and can also be used as a MRI contrast agent. In this study we investigated the use of ferumoxytol as a T2/T2* based MRI contrast reagent in rats at 9.4T. Its very slow wash-out and narrow, unvarying particle size distribution suggest that it may be well suited for rCBV quantification and rCBV-based fMRI.

Keywords

administered affordable agent agents almost alternatives anemia anesthesia application applied approved aspects available besides blood bottom brain carbohydrate carried catheter chronic cited clinical clinically coated coded coil colloidal combined commercially commonly conducted contrast cooperation coronal cortex cost courses curves decrease dementia dependency depicted derived determination diseases distribution dose doses dynamic employed established examination experimental facility faculty field flow gradient great head identical importance in vivo increasing index indicate injection injector intravenous invest investigate iron joint kidney largely light linear little longer longitudinal males mapping maps matrix medical medicine minutes modest molecular monitoring narrow neurological optimized oxide parametric particle particularly peaks pharmaceuticals plot plots post power preparation prohibitive properties quality quantification quoted ranging rapid rare rats reach reactivity reagent regression reliable remained resonator respectively revealed rodent samples scattering secondary significantly slice slices slow spin strong studies sufficiently suggest suitable suited surface tail throughout treatment ultrahigh unvarying useful vascular vein versus vials volume wash zeta